Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rachel Tanner, from the Jenner Institute, has been awarded the 2019 'Woman of the Future award for Science' Prof Helen McShane says: "Rachel is an outstanding scientist.

"Rachel is an outstanding scientist.  Her work has centred around the development, optimisation and establishment of a functional in vitro mycobacterial growth inhibition assay for TB vaccine evaluation. She has led work programmes funded by the European Commission to transfer this assay to other laboratories and in doing so has established herself as a committed, highly effective and successful scientist.   I am delighted that her trajectory and progress has been recognised by this prestigious award"

Similar stories

Côte d’Ivoire becomes first nation to deploy R21 malaria vaccine

Côte d’Ivoire will become the first country to roll-out the new R21/Matrix-M™ vaccine with the first child vaccinated in Abidjan, marking a critical step and historic milestone in the global fight against malaria. 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around 6.6 million children with the malaria vaccine in 2024 and 2025. The new vaccine has been authorised by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments.